Public Site >Sign In  | Register
My Cart
My Cart Summary
Mandatory items may have been added.


Franklin Biotechnology Discovery Fund

Fund Category: SectorGo to Prices & Performance page
showing this category of funds.

Share This Page
Symbol FBDIX
CUSIP 354 713 844
Fund Number 402
Inception Date1 Sep 15, 1997
Distributions Annually
Total Net Assets
(all share classes)
As of 10/31/2015

As of  11/25/2015

NAV2 $180.32  
NAV Change $2.75  
POP3 $191.32  
YTD Total Return at NAV 6.97%
Distribution Rate at NAV N/A
30-day Standardized Yield

Average Annual Total Returns
As of Quarter End 09/30/2015

w/ Sales Charge w/o Sales Charge
1 Yr 0.78% 6.93%
5 Yrs 25.50% 27.00%
10 Yrs 13.27% 13.94%
Life 12.25% 12.62%

Expense Ratio and Sales Charge As of 09/01/2015 (updated annually)

Gross Expense Ratio4 1.00%
Net Expense Ratio 1.00%
Max Initial Sales Charge 5.75%
CDSC 0.00%
12b-1 Fee 0.25%

Fund Description

Strategy Statement
Portfolio Managers
Evan McCulloch
"With the increasing demand for new medical treatments driving earnings growth, and many profitable firms to choose from, we believe now is an exciting time to invest in the biotechnology sector."

Evan McCulloch, CFA®
Joined Franklin Templeton in 1992
Managed Fund Since 1997

Strategy, Benefits, Results


  • We take a bottom-up approach to individual stock selection.
  • We look for companies that possess products with favorable competitive profiles, large market opportunities and strong intellectual property.
  • We favor companies with excellent management, strong financial characteristics and attractive valuations.
  • Our San Francisco Bay Area location is shared by many leading biotechnology companies, enabling us to easily attend scientific meetings and symposia, and to consult with community and academic physicians.


  • Participate in trends moving markets. Invest in innovative sectors—technology, medicine, global communications—we believe are poised for long-term growth.
  • Diversification. By adding investments from different sectors to your portfolio, you may take advantage of expanding and contracting economic cycles.
  • Experienced management. Same lead portfolio manager since the fund's inception in 1997.


Hypothetical $10K Investment

Hypothetical $10K Investment

Investing in the Fund

What Are the Risks?
  • All investments involve risks, including possible loss of principal.
  • Stocks historically have outperformed other asset classes over the long term, but tend to fluctuate more dramatically over the short term.
  • Investment in a non-diversified fund that concentrates in a single sector involves risks such as patent considerations, product liability, government regulatory requirements, and regulatory approval for new drugs and medical products.
  • Biotechnology companies often are small and/or relatively new; as such, smaller companies can be particularly sensitive to changes in economic conditions, have less certain growth prospects than larger, more established companies and can be volatile, especially over the short term.
  • Investments in foreign companies involve special risks, including currency fluctuations and political uncertainty.
  • These and other risks are described more fully in the fund’s prospectus.

Minimum Investment


How Financial Advisors Help You

Speak to your financial advisor about whether this fund is appropriate for you. If you don't have a financial advisor, request a referral.

You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.

Important Legal Information


For US residents only.